Lymphoma & related disorders

Mature T/NK cell disorders

T follicular helper phenotype

EBV+ nodal T and NK cell lymphoma



Last author update: 4 January 2024
Last staff update: 4 January 2024

Copyright: 2021-2024, PathologyOutlines.com, Inc.

PubMed search: EBV+ nodal T and NK cell lymphoma

Michael Stone, D.O.
Carlos A. Murga-Zamalloa, M.D.
Page views in 2023: 230
Page views in 2024 to date: 912
Cite this page: Stone M, Bladek P, Murga-Zamalloa CA. EBV+ nodal T and NK cell lymphoma. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/lymphomaEBVposnodalTNKcell.html. Accessed December 17th, 2024.
Definition / general
  • Primary nodal lymphomas composed of NK or mature T cells with EBV infection in immunocompetent individuals
Essential features
  • Primary nodal T cell lymphoma with EBV positive tumor cells in immunocompetent patients
  • Tumor cells have high grade morphology and frequently show large cells with vesicular nuclei
  • These cases largely represent neoplastic expansions of EBV positive cytotoxic T cell lymphocytes (usually CD8+ with coexpression of TIA1 and granzyme B)
  • The majority of cases have been reported in Asia, are usually diagnosed at an advanced stage and feature a poor median survival time of 3 - 8 months
Terminology
  • EBV positive nodal T or NK cell lymphoma
  • Epstein-Barr virus associated primary nodal T / NK cell lymphoma
ICD coding
  • ICD-10: C84.90 - mature T / NK cell lymphoma, unspecified, unspecified site
  • ICD-11: 2A90 - mature T cell lymphoma, specified types, nodal or systemic
Epidemiology
Sites
Pathophysiology
  • Most of the cases derive from cytotoxic T cell lymphocytes
Etiology
Clinical features
Diagnosis
  • Histological and immunohistochemical examination of lymph node biopsies
Laboratory
Case reports
Treatment
  • Limited data with no standardized treatment
  • No apparent benefit with use of etoposide or anthracycline based chemotherapy approaches
  • Poor response to chemotherapy (Hum Pathol 2015;46:981)
Microscopic (histologic) description
  • Diffuse proliferation of atypical lymphocytes with effacement of the nodal architecture
  • Generally, without conspicuous coagulative necrosis and angioinvasion
  • Neoplastic cells are generally pleomorphic, medium to large and a subset of the tumor cells feature anaplastic morphology
  • References: Am J Surg Pathol 2015;39:462, Hum Pathol 2015;46:981
Microscopic (histologic) images

Contributed by Carlos A. Murga-Zamalloa, M.D.
Diffuse atypical infiltrate

Diffuse atypical infiltrate

Morphological atypia

Morphological atypia

Pleomorphic infiltrate Pleomorphic infiltrate

Pleomorphic infiltrate

Pleomorphism and marked cellular atypia

Pleomorphism and marked cellular atypia

EBV positive lymphocytes (EBER in situ hybridization)

EBV positive lymphocytes (EBER in situ hybridization)

Positive stains
Negative stains
Molecular / cytogenetics description
Sample pathology report
  • Right axillary lymph node, excisional biopsy:
    • Involved by nodal EBV positive NK / T cell lymphoma (see comment)
    • Comment: In situ hybridization for EBV (EBER) shows reactivity in > 30% of the atypical cells.
    • The neoplastic cells feature a cytotoxic immunophenotype (TIA1 / CD8 positive)
    • The overall findings are consistent with EBV+ nodal NK / T cell lymphoma
Differential diagnosis
Additional references
Board review style question #1

The image depicts EBER in situ hybridization in a lymph node. Which of the following is true regarding EBV+ nodal T and NK cell lymphoma?

  1. EBV is positive in background nonneoplastic B cells
  2. Expression of the cytotoxic marker TIA1 and granzyme B is usually absent
  3. Most cases are CD3 / CD4 positive, while CD3 / CD8 positive cases are infrequent
  4. TCR alpha / beta is more common than TCR gamma / delta expression
  5. Usually features a good prognosis with response to anthracycline based chemotherapy
Board review style answer #1
D. TCR alpha / beta is more common than TCR gamma / delta expression. More cases feature TCR alpha / beta expression (~50%) rather than TCR gamma / delta (5%). Answer A is incorrect because in contrast to angioimmunoblastic T cell lymphoma, EBV infection drives the oncogenic process and is positive in the neoplastic T cells and not in the background B cell lymphocytes. Answer B is incorrect because this subtype of T cell lymphoma is characterized by the expansion of cytotoxic T cell lymphocytes with frequent expression of TIA1 and granzyme B. Answer C is incorrect because most cases reported feature neoplastic T cells that are CD3 / CD8 positive; < 5% reported feature CD3 / CD4 positive neoplastic T cells. Answer E is incorrect because patients with a diagnosis of EBV+ nodal T and NK cell lymphoma have poor response to standard chemotherapeutic agents and a median survival of 3 - 8 months.

Comment Here

Reference: EBV+ nodal T and NK cell lymphoma
Board review style question #2

The image depicts EBER in situ hybridization in a lymph node. Which of the following is true regarding EBV+ nodal T / NK cell lymphoma?

  1. By definition, > 80% EBER positivity of the tumor cells are required for the diagnosis of EBV+ nodal T / NK cell lymphoma
  2. Expression of CD30 is detected in most cases
  3. Mutations in the RHOA gene are frequently detected in this lymphoma
  4. There is an overlap in immunophenotypic features with systemic EBV positive T cell lymphoma (SETBL) of childhood; however, EBV+ nodal T / NK lymphoma is predominantly detected in adult populations with primarily nodal disease
  5. This group of T cell lymphomas is clinically characterized by primary orofacial involvement with secondary nodal disease
Board review style answer #2
D. There is an overlap in immunophenotypic features with systemic EBV positive T cell lymphoma (SETBL) of childhood; however, EBV+ nodal T / NK lymphoma is predominantly detected in adult populations with primarily nodal disease. SETBL and EBV+ nodal T / NK lymphoma constitute neoplastic proliferations of cytotoxic T cell lymphocytes; however, SETBL is diagnosed in pediatric populations and EBV+ nodal T / NK lymphoma is predominantly detected in adult populations. Answer A is incorrect because there are no established criteria regarding the percentage of neoplastic T cells for diagnosis; however, many reports included cases with 30% of neoplastic tumor cells positive for EBV by EBER in situ hybridization. Answer B is incorrect because expression of CD30 can be detected in ~20% of the cases and when positive, only a limited number of neoplastic T cells are positive. Answer C is incorrect because mutations in RHOA are predominantly detected in peripheral T cell lymphomas of the T follicular helper type (TFH type), not in EBV+ nodal T / NK lymphomas. Answer E is incorrect because in contrast to extranodal T / NK nasal type lymphoma, EBV+ nodal T / NK lymphoma is primarily nodal without involvement of extranodal sites in the nasal cavity, nasopharynx, oropharynx, Waldeyer ring and epiglottis.

Comment Here

Reference: EBV+ nodal T and NK cell lymphoma
Back to top
Image 01 Image 02